These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3829202)

  • 21. Synthesis, pharmacological effects, and conformation of 4,4-disubstituted 1,4-dihydropyridines.
    Goldmann S; Born L; Kazda S; Pittel B; Schramm M
    J Med Chem; 1990 May; 33(5):1413-8. PubMed ID: 2329562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gating and blocking of calcium channels by dihydropyridines in the pancreatic B-cell.
    Malaisse-Lagae F; Mathias PC; Malaisse WJ
    Biochem Biophys Res Commun; 1984 Sep; 123(3):1062-8. PubMed ID: 6207819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel 1,4-dihydropyridine calcium antagonists. II. Synthesis and antihypertensive activity of 3-[4-(substituted amino)phenylalkyl]ester derivatives.
    Ashimori A; Ono T; Inoue Y; Morimoto S; Eda M; Uchida T; Ohtaki Y; Fujino Y; Kido H; Ogura Y
    Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):91-9. PubMed ID: 2049813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive effect of the new calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl-methyl-4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats.
    Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
    Arzneimittelforschung; 1992 Jan; 42(1):9-16. PubMed ID: 1586389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptor occupation and pharmacokinetics of MPC-1304, a new Ca2+ channel antagonist, in spontaneously hypertensive rats.
    Nozawa Y; Miyake H; Yamada S; Uchida S; Ohkura T; Kimura R
    Eur J Pharmacol; 1995 Dec; 287(2):191-6. PubMed ID: 8749035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of calcium uptake in PC12 cells by the dihydropyridine agonist BAY K 8644.
    Greenberg DA; Carpenter CL; Cooper EC
    J Neurochem; 1985 Sep; 45(3):990-3. PubMed ID: 2411863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of action of the inhibitory effect of nifedipine on the growth of cultured aortic cells from spontaneously hypertensive and normotensive rats.
    Hérembert T; Zhu DL; Marche P
    Br J Pharmacol; 1995 Apr; 114(8):1703-9. PubMed ID: 7541285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Bay K 8644 and nifedipine on femoral arteries of spontaneously hypertensive rats.
    Aoki K; Asano M
    Br J Pharmacol; 1986 May; 88(1):221-30. PubMed ID: 2423174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries.
    Kanda M; Shirahase H; Kurahashi K; Wada K; Nakamura S; Matsui H; Fukata F
    Arzneimittelforschung; 1995 Aug; 45(8):831-5. PubMed ID: 7575741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on the analysis of nifedipine considering in particular transformation products formed by light exposition (author's transl)].
    Ebel S; Schütz H; Hornitschek A
    Arzneimittelforschung; 1978; 28(12):2188-93. PubMed ID: 582929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional vascular effects of MPC-1304, a novel dihydropyridine derivative, in conscious normotensive and spontaneously hypertensive rats.
    Miyoshi K; Kanda A; Nozawa Y; Nakano M; Miyake H
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1328-36. PubMed ID: 8667194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive effect of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride in rats.
    Wada K; Nakamura S; Morishita S; Kanda M; Matsui H; Fukata F; Shirahase H
    Arzneimittelforschung; 1994 Oct; 44(10):1112-6. PubMed ID: 7818582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 1st communication: comparative studies on the cardiovascular effects of methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2,3- b]pyridine-5-carboxylate and its two enantiomers in experimental animals.
    Ueda M; Matsumura S; Masui M; Matsuura E; Uno O; Kawakami M; Ninomiya M; Adachi I
    Arzneimittelforschung; 1993 Dec; 43(12):1270-5. PubMed ID: 8141813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive effects of nisoldipine and reference drugs in certain types of hypertensive rats.
    Tasaka K; Kamei C; Tagami H; Hokonohara T; Sugimoto Y
    Arzneimittelforschung; 1987 Mar; 37(3):316-21. PubMed ID: 3297074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and cardiovascular properties of furazanyl-1,4-dihydropyridines and of furoxanyl analogues.
    Gasco AM; Fruttero R; Sorba G; Gasco A; Budriesi R; Chiarini A
    Arzneimittelforschung; 1992 Jul; 42(7):921-5. PubMed ID: 1418057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of calcium channels by novel 1,4-dihydropyridines. A new mechanism for positive inotropics or smooth muscle stimulants.
    Schramm M; Thomas G; Towart R; Franckowiak G
    Arzneimittelforschung; 1983; 33(9):1268-72. PubMed ID: 6196037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552).
    Kazda S; Garthoff B; Meyer H; Schlossmann K; Stoepel K; Towart R; Vater W; Wehinger E
    Arzneimittelforschung; 1980; 30(12):2144-62. PubMed ID: 7194077
    [No Abstract]   [Full Text] [Related]  

  • 38. The calcium agonists Bay K 8644 and (+)202,791 stimulate the release of endothelial relaxing factor from canine femoral arteries.
    Rubanyi GM; Schwartz A; Vanhoutte PM
    Eur J Pharmacol; 1985 Oct; 117(1):143-4. PubMed ID: 2417863
    [No Abstract]   [Full Text] [Related]  

  • 39. Syntheses and antihypertensive activities of 1,4-dihydropyridine-5-phosphonate derivatives. III.
    Morita I; Haruta Y; Tomita T; Tsuda M; Kandori K; Kise M; Kimura K
    Chem Pharm Bull (Tokyo); 1987 Dec; 35(12):4819-28. PubMed ID: 3451803
    [No Abstract]   [Full Text] [Related]  

  • 40. Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats.
    Karasawa A; Kubo K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1691-4. PubMed ID: 3219141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.